Globus Medical CEO Scavilla resigns; Pfeil named CEO; preliminary Q2 sales $745.3M (+18% YoY)

GLOBUS MEDICAL INC

Daniel Scavilla resigned as President and CEO effective July 18, 2025 to pursue another opportunity; no disagreement cited.
Keith Pfeil, formerly COO/CFO, appointed President and CEO effective July 18, 2025; also joins Board.
Kyle Kline appointed CFO effective July 18, 2025; previously SVP of Finance.
Preliminary Q2 2025 sales ~$745.3M, up 18.4% as reported; base business ex-Nevro up 4.8% day-adjusted.
Full-year 2025 guidance reaffirmed: revenue $2.80–$2.90B, non-GAAP EPS $3.00–$3.30.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.